SBFM News & Events

Sunshine Biopharma's Nora Pharma has received approval from Health Canada for the commercialization of Domperidone, a prescription medication used to relieve nausea and vomiting and to enhance gastrointestinal motility.

Sunshine Biopharma announced the commercial launch of generic Doxycycline in Canada. This strategic move strengthens the Company's footprint in the Canadian growing antibiotic sector. Doxycycline is now available to pharmacies, hospitals and healthcare providers nationwide. Doxycycline is a broad-spectrum antibiotic used to treat respiratory tract infections, urinary tract infections, sexually transmitted diseases, acne, and tick-borne illnesses such as Lyme disease. With high oral bioavailability and a long half-life, Doxycycline continues to be a first-line treatment across multiple antibacterial areas.

Sunshine Biopharma's Nora Pharma has launched Pravastatin, a generic prescription drug in the therapeutic class of Lipid Metabolism Regulators. Pravastatin is a generic version of Pravachol. Pravastatin is a statin medication that works by lowering bad cholesterol and increasing good cholesterol in the blood. This helps prevent heart attacks, strokes, and other serious cardiovascular conditions. With cardiovascular disease remaining a top global health challenge, Nora Pharma is committed to providing effective, accessible treatment options. Nora Pharma's Pravastatin is available in strengths of 10 mg, 20 mg, and 40 mg, and comes in bottles of 100 tablets.

Sunshine Biopharma announced its Board of Directors has formally approved a strategic investment of $5M in Bitcoin as a strategic reserve asset. This move aligns with Sunshine Biopharma's broader strategy to strengthen its financial foundation while advancing its pipeline of generic prescription drugs and proprietary mRNA-based cancer therapies and antiviral drug candidates. The Company's Bitcoin investment of $5M will be executed over time through a regulated digital asset custodian or, the purchase of an ETF or a proxy stock. The Company plans to increase its holdings of Bitcoin by allocating additional funds as such funds become available in the future.